This page shows results related to Alaway and Eye Haemorrhage from the FDA Adverse Event Reporting System (AERS). The adverse event Eye Haemorrhage has been reported to the FDA a total of 1 times for Alaway.
Learn More About Alaway Adverse EventsThe Proportional Reporting Ratio (PRR) for Alaway and Eye Haemorrhage is 4. The chart below compares this proportional reporting ratio of Eye Haemorrhage for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Eye Haemorrhage.
| Eye Haemorrhage | |
| Alaway | 4 |
NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.
Of those reporting Eye Haemorrhage, why were they taking Alaway?
| Seasonal Allergy | 1 |
Which medications reported to the FDA are most commonly associated with Eye Haemorrhage?
| Lucentis | 390 |
| Humalog | 389 |
| Vioxx | 203 |
| Lantus | 198 |
| Humulin N | 196 |
| Humulin R | 133 |
| Plavix | 120 |
| Humulin 70/30 | 97 |
| Gleevec | 92 |
| Forteo | 83 |
| Aspirin | 83 |
 Show More |
